Open Label Extension of LipoLat-CS202

NCT02599688 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 18

Last updated 2020-12-14

Study results available
· View outcomes & findings →

Summary

This is an open-label, observational extension of patients who received POLAT-001 in LipoLat-CS202.

Conditions

Interventions

OTHER

Observation only

No intervention in this study.

Sponsors & Collaborators

  • Peregrine Ophthalmic

    lead INDUSTRY

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-11-30
Primary Completion
2016-06-30
Completion
2016-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02599688 on ClinicalTrials.gov